A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Patent Office Releases GlaxoSmithKline Biologicals's Patent Application for Release Assay for Determining Potency of Self-Amplifying RNA Drug Product and Methods for Using
Published: April 24, 2024 by Pharmaceutical Patent News
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
US Patent Issued to GLAXOSMITHKLINE on April 23 for "Platelet count-agnostic methods of treating myelofibrosis" (Michigan Inventors)
Published: April 24, 2024 by U.S. Fed News
GSK announces partnerships with Second Harvest, FIRST Robotics, and Les Scientifines to expand support for community health, STEM education, and climate health in Canada; new partners were nominated by employees
Published: April 18, 2024 by Canada Newswire
GlaxoSmithkline Biologicals Gets Patent for Process for the Manipulation of Nucleic Acids
Published: April 18, 2024 by Biotechnology Patent News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count